Publications

2020

標的タンパク質分解誘導技術と創薬ベンチャーの動向

Yusuke Tominari and Kanae Gamo, Exp. Med. 38(14), 2020, p2342-2347.

https://www.yodosha.co.jp/jikkenigaku/book/9784758125352/index.html

蛋白質分解誘導剤の開発

Mitsutoshi Wayama, Kanae Gamo, and Yusuke Tominari, J. Mol. Targeted Ther. Cancer, 18(1), 2020, p56-62.

https://www.m-review.co.jp/magazine/detail/J0081_1801

ファイメクス社の標的タンパク分解誘導技術

Yusuke Tominari, Farumasia, 56(3), 2020, p248-250.

https://doi.org/10.14894/faruawpsj.56.3_248


2019

Ligand-induced genetic degradation as a tool for target validation

Aisha Yesbolatova, Yusuke Tominari, and Masato Kanemaki. Drug Diecovery Today, Volume 31, April 2019, p91-98.

https://doi.org/10.1016/j.ddtec.2018.11.001